SPRI | Prehypertension And Cardiometabolic Syndrome (2019 EN)

Discussion in 'Medicine' started by Kanka, Jul 7, 2025.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,395
    Likes Received:
    485
    Trophy Points:
    83
    [​IMG]

    Author: Reuven Zimlichman (Editor), Stevo Julius (Editor), Giuseppe Mancia (Editor)
    Full Title: Prehypertension And Cardiometabolic Syndrome
    Publisher: Springer; 1st ed. 2019 edition (December 20, 2018
    Series: Updates in Hypertension and Cardiovascular Protection
    Year: 2019
    ISBN-13: 9783319753102 (978-3-319-75310-2), 9783319753096 (978-3-319-75309-6)
    ISBN-10: 331975310X, 3319753096
    Pages: 689
    Language: English
    Genre: Medicine: Cardiology
    File type: EPUB (True), PDF (True)
    Quality: 10/10
    Price: 246.09 €


    This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. The book stimulates discussion of this poorly understood condition and lays the groundwork for developing recommendations and guidelines.

    While the diagnostic and therapeutic approach to full-blown diabetes, hypertension, dyslipidemia and obesity is well defined, there is still a lack of clear understanding and guidelines as far as patients with borderline conditions – especially when multiple – are concerned. Moreover, end-organ damage depends on several factors, including genetic factors, making it difficult to predict its extent. As such, the gradual transition from a healthy subject to one with functional hemodynamic changes, and then one with structurally asymptomatic changes and lastly to overt disease needs further investigation.

    In order to address these knowledge gaps, the book covers a broad variety of topics, making it a valuable tool for identifying which asymptomatic subjects could profit from being appropriately screened and at what stage. Furthermore it offers insights into better treating these patients to prevent their progression to overt disease.


    Overview:
    ✓ Provides valuable guidance for identifying which asymptomatic pre-hypertensive subjects could profit from being appropriately screened and treated
    ✓ Fills a knowledge gap and lays the groundwork for developing recommendations and guidelines
    ✓ Will benefit cardiologists, primary care physicians and all those healthcare professional looking to optimally manage these complex and often-undiagnosed cases

    Readership:
    The book appeals to cardiologists, primary care physicians and all those healthcare professional looking to optimize the management of these complex and often undiagnosed cases.

    -------------